Target Cell Limited and Immune Control Models of HIV Infection : A Comparison

We develop various mathematical models of the clinical latency stage of HIV-1 infection assuming that HIV-1 infection is limited either by the availability of cells that HIV can infect or by a specific anti-HIV cellular immune response. The former models we call ‘‘target-cell-limited’’. Comparing the models by phase plane analysis we find that they all belong to the class of predator-prey models. In the target-cell-limited models the virus is a predator feeding upon target cell prey, while in the immune-control models the virus is a prey that is controlled by an immune response predator. Because both classes of models are of predator-prey type they behave similarly in most circumstances. We find that both types of model can account for the generic picture of disease progression in which the CD4 T cell count slowly decreases and the viral load slowly increases. Additionally, we find that both types of models can adequately describe the clinically observed changes in the plasma HIV-1 RNA loads in response to retroviral therapies. 7 1998 Academic Press Limited

[1]  M. Zupancic,et al.  Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. , 1997, Science.

[2]  H. Schuitemaker,et al.  Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics , 1995, The Journal of experimental medicine.

[3]  Peter A. Abrams,et al.  The Fallacies of "Ratio‐Dependent" Predation , 1994 .

[4]  C. Rinaldo,et al.  High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors , 1995, Journal of virology.

[5]  M. Mihatsch,et al.  THE EFFECT OF CYCLOSPORINE ON THE PROGRESSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION TRANSMITTED BY TRANSPLANTATION–DATA ON FOUR CASES AND REVIEW OF THE LITERATURE , 1993, Transplantation.

[6]  M A Savageau,et al.  Network regulation of the immune response: alternative control points for suppressor modulation of effector lymphocytes. , 1985, Journal of immunology.

[7]  A S Perelson,et al.  Modeling HIV infection of CD4+ T-cell subpopulations. , 1994, Journal of theoretical biology.

[8]  J. Coffin,et al.  HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy , 1995, Science.

[9]  B. Larder,et al.  Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects. , 1992, The Journal of infectious diseases.

[10]  A. Perelson,et al.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.

[11]  J M Andrieu,et al.  Effects of cyclosporin on T-cell subsets in human immunodeficiency virus disease. , 1988, Clinical immunology and immunopathology.

[12]  Steven M. Wolinsky,et al.  Adaptive Evolution of Human Immunodeficiency Virus-Type 1 During the Natural Course of Infection , 1996, Science.

[13]  J. Lisziewicz,et al.  Long-term suppression of HIV-1 by hydroxyurea and didanosine. , 1997, JAMA.

[14]  C. Boucher,et al.  Host-parasite dynamics and outgrowth of virus containing a single K70R amino acid change in reverse transcriptase are responsible for the loss of human immunodeficiency virus type 1 RNA load suppression by zidovudine. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Niels Schaft,et al.  T cell telomere length in HIV-1 infection: No evidence for increased CD4+ T cell turnover☆ , 1997 .

[16]  M P Dempsey,et al.  Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. , 1991, Science.

[17]  Lymphocyte dynamics, apoptosis and HIV infection. , 1996, Trends in microbiology.

[18]  David Gray,et al.  Immunological Memory and Protective Immunity: Understanding Their Relation , 1996, Science.

[19]  W. O'brien,et al.  Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. , 1995, Blood.

[20]  Andrew H. Liu,et al.  HIV INFECTION IS ACTIVE AND PROGRESSIVE IN LYMPHOID TISSUE DURING THE CLINICALLY LATENT STAGE OF DISEASE , 1995, Pediatrics.

[21]  J. Levy,et al.  Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. , 1996, Immunology today.

[22]  F. Biron,et al.  1–year follow-up of the use of hydroxycarbamide and didanosine in HIV infection , 1996, The Lancet.

[23]  M A Nowak,et al.  Human immunodeficiency virus drug therapy and virus load , 1997, Journal of virology.

[24]  M A Nowak,et al.  Mathematical biology of HIV infections: antigenic variation and diversity threshold. , 1991, Mathematical biosciences.

[25]  D. Richman,et al.  HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. , 1989, Science.

[26]  T. Elbeik,et al.  Activation of virus replication after vaccination of HIV-1-infected individuals , 1995, The Journal of experimental medicine.

[27]  S. Swindells,et al.  Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine. , 1996, The Journal of infectious diseases.

[28]  H. Resit Akçakaya,et al.  Consequences of Ratio‐Dependent Predation for Steady‐State Properties of Ecosystems , 1992 .

[29]  Hydroxyurea treatment in HIV-infected patients. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[30]  G. Pantaleo.  How immune-based interventions can change HIV therapy , 1997, Nature Medicine.

[31]  M A Savageau,et al.  Network regulation of the immune response: modulation of suppressor lymphocytes by alternative signals including contrasuppression. , 1985, Journal of immunology.

[32]  R. Ellison,et al.  Hepatitis B vaccination and plasma HIV-1 RNA. , 1996, The New England journal of medicine.

[33]  R. J. de Boer,et al.  A Formal Derivation of the “Beddington” Functional Response , 1997 .

[34]  C. Harley,et al.  Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. , 1996, AIDS.

[35]  J. Metcalf,et al.  Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study. , 1995, The New England journal of medicine.

[36]  D Schenzle,et al.  A model for AIDS pathogenesis. , 1994, Statistics in medicine.

[37]  F. Miedema,et al.  Programmed death of T cells in HIV-1 infection. , 1992, Science.

[38]  M. Giacca,et al.  Treatment of human immunodeficiency virus infection with hydroxyurea: virologic and clinical evaluation. , 1996, The Journal of infectious diseases.

[39]  R. D. de Boer,et al.  Diversity and virulence thresholds in AIDS. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[40]  L M Wahl,et al.  Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[41]  A S Perelson,et al.  T cell repertoires and competitive exclusion. , 1994, Journal of theoretical biology.

[42]  Alan S. Perelson,et al.  Decay characteristics of HIV-1-infected compartments during combination therapy , 1997, Nature.

[43]  J. Beddington,et al.  Mutual Interference Between Parasites or Predators and its Effect on Searching Efficiency , 1975 .

[44]  M A Nowak,et al.  Models of interactions between HIV and other pathogens. , 1992, Journal of theoretical biology.

[45]  F. de Wolf,et al.  Biphasic rate of CD4+ cell count decline during progression to AIDS correlates with HIV‐1 phenotype , 1992, AIDS.

[46]  M. Clerici,et al.  Protective immunity against HIV infection: has nature done the experiment for us? , 1996, Immunology today.

[47]  M A Nowak,et al.  Competition between zidovudine‐sensitive and zidovudine‐resistant strains of HIV , 1992, AIDS.

[48]  C. Benson,et al.  Viral Dynamics in Human Immunodeficiency Virus Type 1 Infection , 1995 .

[49]  M A Nowak,et al.  Antigenic diversity thresholds and the development of AIDS. , 1991, Science.

[50]  Alan S. Perelson,et al.  Quantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue , 1996, Science.

[51]  C H Fox,et al.  Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. , 1996, The New England journal of medicine.

[52]  R. Siliciano,et al.  Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.

[53]  M. Cloyd,et al.  How does HIV cause AIDS? The homing theory. , 2000, Molecular medicine today.

[54]  M. Nowak,et al.  Population Dynamics of Immune Responses to Persistent Viruses , 1996, Science.

[55]  W. Lu,et al.  Sustained increases in CD4 cell counts in asymptomatic human immunodeficiency virus type 1-seropositive patients treated with prednisolone for 1 year. , 1995, The Journal of infectious diseases.

[56]  A. Hastings,et al.  Chaos in a Three-Species Food Chain , 1991 .

[57]  A. Perelson,et al.  HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.

[58]  C. Boucher,et al.  Clinical data sets of human immunodeficiency virus type 1 reverse transcriptase-resistant mutants explained by a mathematical model , 1997, Journal of virology.

[59]  John W. Mellors,et al.  Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.

[60]  D. Ho,et al.  Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression , 1994, Journal of virology.

[61]  A. Fauci,et al.  Multifactorial nature of human immunodeficiency virus disease: implications for therapy. , 1993, Science.

[62]  S. Staszewski,et al.  Turnover of circulating virion RNA and of cell-associated viral DNA reflects active viral replication in human immunodeficiency virus type 1-infected individuals , 1995, Journal of virology.

[63]  Lange,et al.  Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates , 1989, Journal of virology.

[64]  T. Kirkwood,et al.  A model of human immunodeficiency virus infection in T helper cell clones. , 1990, Journal of theoretical biology.

[65]  L. Corey,et al.  Reducing T cell activation as a therapy for human immunodeficiency virus infection. , 1995, The Journal of infectious diseases.

[66]  C. Boucher,et al.  Anti-CD4 therapy for AIDS suggested by mathematical models , 1996, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[67]  Andrew N. Phillips,et al.  Reduction of HIV Concentration During Acute Infection: Independence from a Specific Immune Response , 1996, Science.

[68]  M A Nowak,et al.  HIV results in the frame. Results confirmed. , 1995, Nature.

[69]  Xiping Wei,et al.  Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus , 1997, Nature Medicine.

[70]  D. Weissman,et al.  Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. , 1996, Journal of immunology.

[71]  Martin A. Nowak,et al.  Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS , 1997, Nature Medicine.

[72]  S. Frost,et al.  Quasispecies dynamics and the emergence of drug resistance during zidovudine therapy of HIV infection , 1994, AIDS.

[73]  B L Levine,et al.  Human naive and memory T lymphocytes differ in telomeric length and replicative potential. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[74]  S Galpin,et al.  HIV results in the frame. Cyclosporin A. , 1995, Nature.

[75]  A S Perelson,et al.  Towards a general function describing T cell proliferation. , 1995, Journal of theoretical biology.